321 related articles for article (PubMed ID: 32198200)
1.
Mileto SJ; Jardé T; Childress KO; Jensen JL; Rogers AP; Kerr G; Hutton ML; Sheedlo MJ; Bloch SC; Shupe JA; Horvay K; Flores T; Engel R; Wilkins S; McMurrick PJ; Lacy DB; Abud HE; Lyras D
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8064-8073. PubMed ID: 32198200
[TBL] [Abstract][Full Text] [Related]
2. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
3. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
4. Murine Intrarectal Instillation of Purified Recombinant
Markham NO; Bloch SC; Shupe JA; Laubacher EN; Thomas AK; Kroh HK; Childress KO; Peritore-Galve FC; Washington MK; Coffey RJ; Lacy DB
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33468584
[No Abstract] [Full Text] [Related]
5. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.
Tao L; Zhang J; Meraner P; Tovaglieri A; Wu X; Gerhard R; Zhang X; Stallcup WB; Miao J; He X; Hurdle JG; Breault DT; Brass AL; Dong M
Nature; 2016 Oct; 538(7625):350-355. PubMed ID: 27680706
[TBL] [Abstract][Full Text] [Related]
6. The role of toxins in Clostridium difficile infection.
Chandrasekaran R; Lacy DB
FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
[TBL] [Abstract][Full Text] [Related]
7. A new role for heat shock factor 27 in the pathophysiology of
Yanda MK; Guggino WB; Cebotaru L
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G120-G129. PubMed ID: 31709831
[No Abstract] [Full Text] [Related]
8. Plakoglobin and High-Mobility Group Box 1 Mediate Intestinal Epithelial Cell Apoptosis Induced by Clostridioides difficile TcdB.
Li Y; Xu W; Ren Y; Cheung HC; Huang P; Kaur G; Kuo CJ; McDonough SP; Fubini SL; Lipkin SM; Deng X; Chang YF; Huang L
mBio; 2022 Oct; 13(5):e0184922. PubMed ID: 36043787
[TBL] [Abstract][Full Text] [Related]
9. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
Pan Z; Zhang Y; Luo J; Li D; Zhou Y; He L; Yang Q; Dong M; Tao L
PLoS Pathog; 2021 Jan; 17(1):e1009197. PubMed ID: 33507919
[TBL] [Abstract][Full Text] [Related]
10. A Colonic Organoid Model Challenged with the Large Toxins of
Schneemann M; Heils L; Moos V; Weiß F; Krug SM; Weiner J; Beule D; Gerhard R; Schulzke JD; Bücker R
Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999506
[TBL] [Abstract][Full Text] [Related]
11. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.
Leslie JL; Huang S; Opp JS; Nagy MS; Kobayashi M; Young VB; Spence JR
Infect Immun; 2015 Jan; 83(1):138-45. PubMed ID: 25312952
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses.
Bassotti G; Marchegiani A; Marconi P; Fettucciari K
Microbiologyopen; 2020 Aug; 9(8):e1061. PubMed ID: 32657021
[TBL] [Abstract][Full Text] [Related]
13. Receptor Binding Domains of TcdB from
Henkel D; Tatge H; Schöttelndreier D; Tao L; Dong M; Gerhard R
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255261
[TBL] [Abstract][Full Text] [Related]
14. Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.
Rodrigues RS; Oliveira RA; Li Y; Zaja-Milatovic S; Costa LB; Braga Neto MB; Kolling GL; Lima AA; Guerrant RL; Warren CA
J Infect Dis; 2013 May; 207(10):1505-15. PubMed ID: 23359592
[TBL] [Abstract][Full Text] [Related]
15. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early
Ok MT; Liu J; Bliton RJ; Hinesley CM; San Pedro EET; Breau KA; Gomez-Martinez I; Burclaff J; Magness ST
Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G262-G280. PubMed ID: 36749911
[No Abstract] [Full Text] [Related]
16. Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B.
Guo S; Chen Y; Liu J; Zhang X; Liu Z; Zhou Z; Wei W
Sci China Life Sci; 2022 Jan; 65(1):107-118. PubMed ID: 34279819
[TBL] [Abstract][Full Text] [Related]
17. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
[TBL] [Abstract][Full Text] [Related]
18. Identification of the role of toxin B in the virulence of Clostridioides difficile based on integrated bioinformatics analyses.
Gao Y; Gao W; Cheng J; Ma L; Su J
Int Microbiol; 2020 Nov; 23(4):575-587. PubMed ID: 32388701
[TBL] [Abstract][Full Text] [Related]
19. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
